Patents Assigned to Life Technologies, Inc.
  • Publication number: 20020174878
    Abstract: An apparatus for washing magnetic particles including a well plate for receiving an array tube holder having x rows of tubes, each tube containing magnetic particles, the well plate having (x+1) rows of wells for enabling the array tube holder to be shifted from a first position to a second position. The apparatus also includes ((x/2)+1) rows of magnets asymmetrically positioned within the well plate adjacent to the rows of wells. Placing the array tube holder in the first position causes magnetic fields produced by each magnet to attract the magnetic particles in the x rows of tubes to one side of each tube, and shifting the array tube holder to the second position reverses the magnetic fields, causing the magnetic particles to stream across to the other side of each tube. The array tube holder may be a 96 tube array tube holder (8 rows by 12 columns) in which case, the well plate includes 108 wells (9 rows by 12 columns) for simultaneously washing 96 tubes.
    Type: Application
    Filed: May 10, 2002
    Publication date: November 28, 2002
    Applicant: Life Technologies, Inc.
    Inventors: Paul E. Nisson, Michael W. Schuette, Wu Bo Li
  • Patent number: 6432143
    Abstract: A method and apparatus for continuously preparing a medium formulation mixes a diluent with a plurality of chemically incompatible concentrate solutions in such a manner that none of the ingredients of the concentrate solutions chemically react in an adverse manner. The method utilizes a static mixing chamber to add the concentrate solutions to the diluent stream sufficiently in advance of one another so that adverse chemical reactions do not occur. The method also adjusts a pH level of the diluent prior to adding any of the concentrate solutions to the diluent.
    Type: Grant
    Filed: February 23, 2001
    Date of Patent: August 13, 2002
    Assignee: Life Technologies, Inc.
    Inventors: James M. Kubiak, Todd A. Battistoni, David W. Jayme
  • Patent number: 6376248
    Abstract: The present invention provides compositions useful for transfecting eukaryotic cells comprising nucleic acid complexes with peptides, wherein the peptide is optionally covalently coupled to a nucleic acid-binding group, and cationic lipids or dendrimers as transfection agents. The invention also provides transfection compositions in which a peptide is covalently linked to the transfection agent (lipid, cationic lipid or dendrimer). Inclusion of peptides or modified-peptides in transfection compositions or covalent attachment of peptides to transfection agents results in enhanced transfection efficiency. Methods for the preparation of transfection compositions and methods of using these transfection compositions as intracellular delivery agents and extracellular targeting agents are also disclosed.
    Type: Grant
    Filed: March 16, 1998
    Date of Patent: April 23, 2002
    Assignee: Life Technologies, Inc.
    Inventors: Pamela Hawley-Nelson, Jianqing Lan, PoJen Shih, Joel A. Jessee, Kevin P. Schifferli, Gulilat Gebeyehu, Valentina C. Ciccarone, Krista L. Evans
  • Patent number: 6361999
    Abstract: The present invention provides compounds and compositions capable of stimulating plant growth, regeneration of plant cells and tissues, and transformation of plant cells and tissues, comprising mono- and multi-substituted auxinic analogues of indole-3-acetic acid (IAA) comprising substituent groups such as halo-, alkyl-, alkoxy-, acyl-, acylamido- and acyloxy-groups. The invention relates to a method of using such mono- and multi-substituted auxinic analogues of IAA to affect growth, regeneration or transformation in monocotyledonous and dicotyledonous plants, as well as in transgenic plant tissues. The invention also contemplates the use of these auxinic IAA analogues in the presence of other plant growth regulators, such as cytokinin, etc., to enhance plant growth.
    Type: Grant
    Filed: November 29, 1996
    Date of Patent: March 26, 2002
    Assignee: Life Technologies, Inc.
    Inventors: Jhy-Jhu Lin, Jianqing Lan, Nacyra Assad-Garcia
  • Patent number: 6171861
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: January 12, 1998
    Date of Patent: January 9, 2001
    Assignee: Life Technologies, Inc.
    Inventors: James L. Hartley, Michael A. Brasch
  • Patent number: 6143557
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: January 20, 1999
    Date of Patent: November 7, 2000
    Assignee: Life Technologies, Inc.
    Inventors: James L. Hartley, Michael A. Brasch
  • Patent number: 6110916
    Abstract: The present invention discloses highly packed polycationic ammonium, sulfonium and phosphonium lipid compounds useful for making lipid aggregates for delivery of macromolecules and other compounds into cells. They are especially useful for the DNA-dependent transformation of cells. Methods for their preparation and use as intracellular delivery agents are also disclosed.
    Type: Grant
    Filed: November 6, 1998
    Date of Patent: August 29, 2000
    Assignee: Life Technologies, Inc.
    Inventors: Alberto Haces, Valentina C. Ciccarone
  • Patent number: 6103529
    Abstract: The present invention provides serum-free cell culture media formulations which are capable of supporting the in vitro cultivation of animal cells. The media comprise at least one nutrient of plant derivation, such as at least one plant peptide and/or at least one plant lipid and/or at least one plant fatty acid. The media may further optionally comprise an enzymatic digest or extract of yeast cells. The present invention also provides methods of cultivating animal cells in vitro using these cell culture media formulations. In addition, the media of the present invention can be used for growth of animal cells for virus production.In particular, an animal cell culture medium comprising at least one peptide derived from rice, wherein said animal cell culture medium is completely devoid of animal-derived proteins.
    Type: Grant
    Filed: October 10, 1997
    Date of Patent: August 15, 2000
    Assignee: Life Technologies, Inc.
    Inventors: Paul J. Price, Steve Gorfien, Douglas Danner
  • Patent number: 6075012
    Abstract: The present invention discloses cationic lipids and lipophilic compounds useful for making lipid aggregates for delivery of macromolecules and other compounds into cells. They are especially useful for the DNA-dependent transformation of cells. Also disclosed are compositions of cationic lipids and viral components or non-viral fusagenic compounds useful for enhancing transfection.
    Type: Grant
    Filed: February 11, 1994
    Date of Patent: June 13, 2000
    Assignee: Life Technologies, Inc.
    Inventors: Gulilat Gebeyehu, Joel A. Jessee
  • Patent number: 6063608
    Abstract: The invention relates to a gene which encodes reverse transcriptase having DNA polymerase activity and substantially no RNase H activity. The invention also relates to vectors containing the gene and hosts transformed with the vectors of the invention. The invention also relates to a method of producing reverse transcriptase having DNA polymerase activity and substantially no RNase H activity by expressing the reverse transcriptase genes of the present invention in a host. The invention also relates to a method of producing cDNA from mRNA using the reverse transcriptase of the invention. The invention also relates to a kit for the preparation of cDNA from mRNA comprising the reverse transcriptase of the invention.
    Type: Grant
    Filed: February 10, 1997
    Date of Patent: May 16, 2000
    Assignee: Life Technologies, Inc.
    Inventors: Michael Leslie Kotewicz, Gary Floyd Gerard
  • Patent number: 6051429
    Abstract: The present invention provides compositions useful for transfecting eukaryotic cells comprising nucleic acid complexes with peptides, wherein the peptide is optionally covalently coupled to a nucleic acid-binding group, and cationic lipids or dendrimers as transfection agents. The invention also provides transfection compositions in which a peptide is covalently linked to the transfection agent (lipid, cationic lipid or dendrimer). Inclusion of peptides or modified-peptides in transfection compositions or covalent attachment of peptides to transfection agents results in enhanced transfection efficiency. Methods for the preparation of transfection compositions and methods of using these transfection compositions as intracellular delivery agents and extracellular targeting agents are also disclosed.
    Type: Grant
    Filed: March 14, 1997
    Date of Patent: April 18, 2000
    Assignee: Life Technologies, Inc.
    Inventors: Pamela Hawley-Nelson, Jianqing Lan, PoJen Shih, Joel A. Jessee, Kevin P. Schifferli, Gulilat Gebeyehu
  • Patent number: 6045697
    Abstract: This invention relates generally to modified porous solid supports and processes for the preparation and use of same. In particular, passivated porous supports are disclosed which are characterized by a reversible high sorptive capacity substantially unaccompanied by non-specific adsorption of or interaction with biomolecules. Passivation is achieved by use of a passivation mixture comprising a main monomer, a passivating agent comprising polyethyleneimine, and a crosslinking agent, which mixture upon polymerization results in the substantial elimination of the undesirable non-specific interaction with biomolecules.
    Type: Grant
    Filed: November 30, 1998
    Date of Patent: April 4, 2000
    Assignee: Life Technologies, Inc.
    Inventors: Pierre Girot, Egisto Boschetti
  • Patent number: 6041515
    Abstract: An apparatus and method for quickly drying solutions in one or more arrays of vessels includes a manifold that receives gas and a base plate that receives the one or more arrays of vessels. The manifold includes one or more hollow tubes that direct the gas into the vessels, where the gas evaporates the solutions. A variety of types of hollow tubes are disclosed. In an exemplary embodiment, the gas is filtered, pressurized and/or heated. In an exemplary embodiment, the solutions are heated. The base plate is hingeably coupled to the manifold so that the base plate has an open position and a closed position. The open position permits users to place and remove the vessels that contain solutions to be dried. In the closed position, the base plate and the manifold are in sealing engagement with one another, wherein the one or more of the hollow tubes extend into the vessels.
    Type: Grant
    Filed: January 12, 1998
    Date of Patent: March 28, 2000
    Assignee: Life Technologies, Inc.
    Inventors: Abdul H. Ally, Brent W. Henry, Michael W. Schuette
  • Patent number: 6020202
    Abstract: The present invention provides compositions and methods for transfecting eukaryotic cells which comprise a nucleic acid, a cationic lipid capable of forming a complex with said nucleic acid, and a viral agent which is an active or inactive enveloped virus or a component of an enveloped virus. Particular viral agents include alpharviruses and components thereof.
    Type: Grant
    Filed: November 18, 1996
    Date of Patent: February 1, 2000
    Assignee: Life Technologies, Inc.
    Inventor: Joel A. Jessee
  • Patent number: 6015668
    Abstract: The invention relates to a substantially pure thermostable DNA polymerase from Thermotoga (Tne and Tma) and mutants thereof. The Tne DNA polymerase has a molecular weight of about 100 kilodaltons and is more thermostable than Taq DNA polymerase. The mutant DNA polymerase has at least one mutation selected from the group consisting of (1) a first mutation that substantially reduces or eliminates 3'.fwdarw.5' exonuclease activity of said DNA polymerase; (2) a second mutation that substantially reduces or eliminates 5'.fwdarw.3' exonuclease activity of said DNA polymerase; (3) a third mutation in the O helix of said DNA polymerase resulting in said DNA polymerase becoming non-discriminating against dideoxynucleotides. The present invention also relates to the cloning and expression of the wild type or mutant DNA polymerases in E. coli, to DNA molecules containing the cloned gene, and to host cells which express said genes.
    Type: Grant
    Filed: September 6, 1996
    Date of Patent: January 18, 2000
    Assignee: Life Technologies, Inc.
    Inventors: A. John Hughes, Deb K. Chatterjee
  • Patent number: 6004025
    Abstract: A method for continuously preparing a medium formulation mixes a diluent with a plurality of chemically incompatible concentrate solutions in such a manner that none of the ingredients of the concentrate solutions chemically react in an adverse manner The method utilizes a static mixing chamber to add the concentrate solutions to the diluent stream sufficiently in advance of one another so that adverse chemical reactions do not occur. The method also adjusts a pH level of the diluent prior to adding any of the concentrate solutions to the diluent.
    Type: Grant
    Filed: May 16, 1997
    Date of Patent: December 21, 1999
    Assignee: Life Technologies, Inc.
    Inventors: James M. Kubiak, Todd A. Battistoni, David W. Jayme
  • Patent number: 5994135
    Abstract: The present invention describes the use of 5-bromoindole-3-acetic acid (5-B-IAA) as an auxin affecting plant cell growth. The invention relates to the use of 5-B-IAA compositions to affect growth in monocotyledonous as well as in dicotyledonous plants. The invention also describes the use of 5-B-IAA in plant growth affecting compositions for the regeneration of both plant tissues and transgenic plant tissues. Further, the invention provides plant growth affecting compositions comprising 5-B-IAA alone or in a mixture comprising one or more additional plant growth regulators, such as cytokinin, etc.
    Type: Grant
    Filed: May 22, 1997
    Date of Patent: November 30, 1999
    Assignee: Life Technologies, Inc.
    Inventors: Jhy-Jhu Lin, Jianqing Lan, Nacyra Assad-Garcia
  • Patent number: 5981736
    Abstract: A device for one step purification of a desired biological molecule from a sample, wherein the device comprises a housing loaded with an adsorptive media of a known volume on top of a size exclusion media of a known volume, and a method of purifying biological molecules using the same.
    Type: Grant
    Filed: June 25, 1998
    Date of Patent: November 9, 1999
    Assignee: Life Technologies, Inc.
    Inventor: Jonathan L. Coffman
  • Patent number: 5970782
    Abstract: Particles such as bacteria may be enumerated from a liquid in an accurate and efficient manner through use of an apparatus including a filter sheet which is oriented transverse to the surface of the liquid being filtered. The filter sheet is so arranged so that, as the liquid is filtered, an increasing portion of the filter is above the surface of the liquid. As a result of the surface of the liquid dropping across the filter, a smaller fraction of the total volume of the liquid passes through the upper portion of the filter than through the lower portion of the filter. Since the number of bacteria trapped per unit area of the filter depends on the volume filtered through the area, a monotonically increasing gradient of density of filtered bacteria occurs from the top to the bottom of the filter.
    Type: Grant
    Filed: May 15, 1998
    Date of Patent: October 26, 1999
    Assignee: Life Technologies, Inc.
    Inventors: James L. Hartley, Terry A. Landers
  • Patent number: 5965399
    Abstract: The invention relates to the cloning of a gene encoding rat liver ribonuclease inhibitor (RI), and its expression in a cellular host. In addition, the invention relates to the successful cloning of a gene encoding porcine liver RI, and its expression in a cellular host.
    Type: Grant
    Filed: February 4, 1997
    Date of Patent: October 12, 1999
    Assignee: Life Technologies, Inc.
    Inventors: Deb K. Chatterjee, Harini Shandilya